All posts
-
Decmil secures contract for Pilbara’s West Angelas project
Decmil, a completely had subsidiary of Macmahon, has actually safeguarded an agreement from Rio Tinto, valued at A$ 120m ($ 80.41 m), for the West Angelas Sustaining Task positione…
-
The most impactful AI in farming ‘will not feel revolutionary,’ says Phospholutions boss. It will feel ‘dependable’
“Soil health isn’t an abstract sustainability goal,” says Hunter Swisher. “It’s a systems strategy for producing what the world needs with the resources we have.” In other words, i…
-
Former Leo Pharma boss steps down as CEO of Newbury Pharmaceuticals
Difference over tactical instructions has actually led the board of supervisors and the previous chief executive officer of Leo Pharma to end their cooperation.
-
Analyst sees no impact on long-term outlook from new Genmab data
Genmab’s share cost decrease adhering to brand-new information is an overreaction, claims Mattias Häggblom of Svenska Handelsbanken.
-
Major drugmakers hesitant to use FDA’s new fast-track program
Numerous firms are afraid lawful dangers if fast authorizations are later on tested.
-
Novo Nordisk challenges Eli Lilly’s claims about new weight-loss pill
Danish drugmaker takes an uncommonly straight strategy in slamming its rival’s cases concerning the effectiveness, adverse effects and use weight-loss tablet computers.
-
Analyst upbeat as US launch of Wegovy tablet drives shares higher
Novo Nordisk shares get on motivating signals from Wegovy tablet rollout, however an elderly expert advises care over very early prescription numbers.
-
European allies work on response to Trump’s tariff threat
To Name A Few, Emmanuel Macron, Keir Starmer and Ursula von der Leyen assistance Denmark and caution Trump versus waging toll risks.
-
Genmab shows promising results again with cancer drug in new Phase 3 study
The Danish firm anticipates to be able to existing information from 2 various other researches later on in 2026.
